Study: 3 genetic changes could predict prostate cancer survival

01/27/2010 | Reuters

Prostate cancer patients carrying genetic abnormalities -- deletion of the PTEN gene as well as ERG or ETV1 gene rearrangement -- had lower chances of survival than those who had none of the gene mutations, U.K. scientists found. "Men diagnosed with prostate cancer could be tested for all three genetic alterations, and this information could be used to help determine how aggressively they should be treated," the study's lead researcher said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX